mots c vs cjc 1295 ipamorelin CJC-1295 and MOTS-c: A Powerful Duo for Bone Support in Perimenopause During perimenopause, estrogen decline accelerates bone loss. But emerging peptides like CJC-1295 and MOTS-c may help reverse that trajectory. CJC-1295 stimulates Two Doctors Audit the Peptide
Description
Reduces dryness, flakiness & rough texture
Anemia may make you feel tired, weak, and short of breath
At a release dose of 500 iu every 3 days, via a subcutaneous route, we would see something like this: Figure 12 Approximate average daily release of HCG at 500iu every 3.5 days, via subcutaneous administration It should be noted that this does not show the biphasic nature of HCG, where a subsequent peak will occur
Karako, E., Halal, S
